|
End-of-day quote
Australian S.E.
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Nash
CEO | Chief Executive Officer | - | - |
Andrew Boyd
DFI | Director of Finance/CFO | - | 2011-02-28 |
| Corporate Officer/Principal | - | 2011-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Nash
BRD | Director/Board Member | - | 2011-02-28 |
Brian McNamee
BRD | Director/Board Member | 70 | - |
Antoni M. Cipa
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| +0.71% | +2.30% | +54.03% | +66.22% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +3.32% | +3.51% | +35.43% | +57.63% | 294B | |
| +1.99% | +0.17% | +3.52% | +27.25% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +2.14% | +1.39% | +41.38% | +76.74% | 448.57B | |
| Weighted average by Cap. | +2.48% | +1.50% | +45.03% | +89.28% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ZTL Stock
Select your edition
All financial news and data tailored to specific country editions
